Ischemic heart disease (IHD) remains the leading cause of mortality globally, despite advancements in pharmacotherapy and revascularization techniques that ...
trientine hydrochloride is under development for treatment of ischemic heart disease, chronic heart failure, myocardial infarction, left ventricular ejection fraction and amyloidosis. It is ...